Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
13.43x1.05x0.47x1.88x7.54x9.93x2.5% 7.26B
19.95x2.36x-4.14x4.61x13.06x14.15x0.5% 80.81B
28.91x4.03x2.64x5.74x16.61x21.07x0.55% 58.24B
41.32x6.16x1.09x12.42x23.04x26.86x-.--% 47.98B
35.86x2.5x-0.66x3.64x10.5x11.92x2.86% 48.55B
16.05x1.37x0.46x2.95x8.59x9.51x-.--% 27.88B
-8.66x3.3x1.08x9.23x-7.42x-6.79x-.--% 22.83B
15.54x2.68x-20.85x2.53x8.01x7.53x-.--% 19.67B
69.04x6.85x-0.04x8.11x81.08x77.99x-.--% 17.22B
649.92x3.36x-6.86x5.07x12.97x45.13x-.--% 14.56B
253.31x49.95x19.95x85.02x154.79x160.1x - 12.14B
-35.04x-5.48x0.7x15.87x-44.26x-51.91x-.--% 12.9B
14.06x - 0.1x3.1x13.51x24.69x-.--% 11.62B
-190.76x97.28x2.49x8.28x208.01x-181.76x-.--% 8.39B
33.82x - 2.32x - - - -.--% 7.75B
-209.9x - 0.64x - - - -.--% 6.95B
4.43x1.72x0.01x1.82x2.71x2.75x4.21% 6.28B
20.57x1.21x-2.26x - - - 1.3% 5.9B
-11.71x1.19x0.05x3.57x-23.87x-24.33x-.--% 5.42B
Average 40.01x 11.22x -0.15x 10.87x 30.30x 9.18x 0.66% 22.23B
Weighted average by Cap. 43.56x 6.46x -0.82x 8.52x 21.42x 16.15x 0.64%
Biopharmaceuticals